Weed, Inc. (BUDZ): Revenue
$0
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | n/a | 2026-04-08, From 2025-01-01 |
| 2024-12-31 | $0 | n/a | 2026-04-08, From 2024-01-01 |
| 2023-12-31 | $0 | n/a | 2024-04-01, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2024-04-01, From 2022-01-01 |
| No annual figure between 2020-12-31 and 2022-12-31. | |||
| 2020-12-31 | $0 | n/a | 2021-03-31, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $0 | n/a | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $0 | n/a | 2019-04-16, From 2017-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Weed, Inc. (BUDZ) | 2025-12-31 | $0 | n/a |
| NRC Health (NRC) | 2025-12-31 | $137.39M | -4.0% |
| Incyte Corp (INCY) | 2025-12-31 | $5.14B | +21.2% |
| Icon PLC (ICLR) | 2025-12-31 | $8.25B | +0.8% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $4.02B | -0.9% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $33.03M | -14.5% |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | $303.0K | +21.8% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $16.31B | +5.9% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $1.93M | -79.2% |
Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗